Working… Menu

Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasi

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03897088
Recruitment Status : Active, not recruiting
First Posted : April 1, 2019
Last Update Posted : February 11, 2021
Information provided by (Responsible Party):
Sun Pharma Global FZE

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 13, 2021
Estimated Study Completion Date : February 2022